Nektar Therapeutics
NKTR NASDAQ







Weekly Summary
Nektar Therapeutics closed at 55.1400 (-6.16% WoW) . Data window ends Fri, 19 Sep 2025.
How to read this — Price slope is upward, indicating persistent buying over the window. Elevated weekly volatility increases whipsaw risk. Volume and price are moving in the same direction — a constructive confirmation. Constructive MA stack supports the up-drift; pullbacks may find support at the 8–13 week region. Price holds above key averages, indicating constructive participation.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm.
Gauge maps the trend signal to a 0–100 scale.
How to read this — Gauge is elevated but momentum is rolling over; topping risk is rising.
Stay alert: protect gains or seek confirmation before adding risk.

Relative strength is Positive
(> 0%, outperforming).
Latest MRS: 141.08% (week ending Fri, 19 Sep 2025).
Slope: Rising over 8w.
Notes:
- Holding above the zero line indicates relative bid.
- MRS slope rising over ~8 weeks.
Conclusion
Neutral setup. ★★★⯪☆ confidence. Trend: Uptrend at Risk · 140.16% over window · vol 4.90% · liquidity convergence · posture above · RS outperforming · leaning positive
- Momentum is bullish and rising
- Price holds above 8–26 week averages
- Constructive moving-average stack
- Liquidity confirms the price trend
- High level but momentum rolling over (topping risk)
- High return volatility raises whipsaw risk
Why: Price window 140.16% over w. Close is 13.27% above the prior-window high. Return volatility 4.90%. Volume trend rising. Liquidity convergence with price. Trend state uptrend at risk. MA stack constructive. Baseline deviation 1.89% (widening). Momentum bullish and rising.
Tip: Most metrics include a hover tooltip where they appear in the report.